Effect of lithium carbonate on COVID-19

Phase 2

Recruiting

• Conditions: covid-19.; COVID-19 Disease; U07.1

• Registration Number: IRCT20081019001369N5
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients with covid-19 symptoms
Indication of home quarantine
outpatients
aged range 18-65 uears old

Exclusion Criteria

Patients connected to acatheter or under chemotherapy
Patients taking cytotoxic drugs or corticosteroids
Patients having a psychological problem now or in the past or with a history of psychological problem in first class family
Patients who used cigarette at least one month before the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time interval until clinical symptoms improve. Timepoint: 3 days, 1 week and 2 weeks after treatment. Method of measurement: time of recovery.

Secondary Outcome Measures

Name	Time	Method
Fever. Timepoint: 3 days, 1 week and 2 weeks after treatment. Method of measurement: Thermometer.;Lymphopenia. Timepoint: 3 days, 1 week and 2 weeks after treatment. Method of measurement: Cell counter device.;CRP. Timepoint: 3 days, 1 week and 2 weeks after treatment. Method of measurement: CRP kit.